Cardinal Health Stock - Analyst consensus and valuation snapshot

Cardinal Health sits on a Moderate Buy consensus with a double-digit implied upside, while recent filings highlight shifting hedge fund positions. A closer look at analyst targets and valuation puts the current share price into perspective for retail investors.

Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/18/2026, 16:46 CET. Details in the imprint.

Cardinal Health (US14149Y1082) carries a Moderate Buy analyst consensus and trades at a discount to average price targets, according to current data from MarketBeat.

What recent filings show

Recent SEC filings point to active hedge fund positioning in Cardinal Health shares. Empyrean Capital Partners cut its stake by roughly 30.7% in the fourth quarter, selling 109,600 shares and holding 247,800 shares afterward, according to a 13F report summarized by MarketBeat.

On the other side, Advanced Portfolio Management opened or increased a position with the purchase of 5,157 Cardinal Health shares in the same period, according to another MarketBeat filing summary. These moves underline that institutional investors are continuously recalibrating their exposure.

Analyst consensus and price targets today

Across 17 analysts tracked by MarketBeat, Cardinal Health currently holds an average rating of Moderate Buy with a consensus 12-month price target of about $246.93 per share. The target range runs from a low of $208.00 to a high of $275.00.

Based on a recent closing price around $226.29, the consensus implies roughly 9% upside potential from current levels, according to the same MarketBeat overview. That positions Cardinal Health as a moderately valued healthcare distributor with room for appreciation if it delivers on earnings expectations.

The business behind the stock

Cardinal Health generates most of its revenue as a large pharmaceutical and medical products distributor in the United States and internationally. The company supplies branded and generic drugs, as well as medical and surgical products, to hospitals, pharmacies and other healthcare providers.

Where the stock trades today

Cardinal Health shares (US14149Y1082) trade on the New York Stock Exchange under the ticker CAH; the most recently verified price was approximately $226.29 in U.S. dollars as of the latest regular session close on 06/17/2026.

Key facts on Cardinal Health stock

• Company: Cardinal Health, Inc.
• ISIN: US14149Y1082
• WKN: 879312
• Ticker: CAH
• Venue: NYSE
• Price (as of 06/17/2026, 16:00 ET): 226.29 USD
• Market cap: approximately 55 billion USD (as of 06/17/2026)
• Sector / Industry: Health Care / Health Care Distributors
• Index membership: Standard & Poor's 500 index
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.